These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15138382)
1. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Chondrogianni N; Gonos ES Biogerontology; 2004; 5(1):55-61. PubMed ID: 15138382 [TBL] [Abstract][Full Text] [Related]
2. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. Chondrogianni N; Stratford FL; Trougakos IP; Friguet B; Rivett AJ; Gonos ES J Biol Chem; 2003 Jul; 278(30):28026-37. PubMed ID: 12736271 [TBL] [Abstract][Full Text] [Related]
3. Cellular senescence in human keratinocytes: unchanged proteolytic capacity and increased protein load. Brégégère F; Soroka Y; Bismuth J; Friguet B; Milner Y Exp Gerontol; 2003 Jun; 38(6):619-29. PubMed ID: 12814797 [TBL] [Abstract][Full Text] [Related]
4. Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts. Torres C; Francis MK; Lorenzini A; Tresini M; Cristofalo VJ Exp Cell Res; 2003 Nov; 290(2):195-206. PubMed ID: 14567979 [TBL] [Abstract][Full Text] [Related]
5. An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype. Stephens P; Cook H; Hilton J; Jones CJ; Haughton MF; Wyllie FS; Skinner JW; Harding KG; Kipling D; Thomas DW Exp Cell Res; 2003 Feb; 283(1):22-35. PubMed ID: 12565817 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of proteasome function induced apoptosis in gastric cancer. Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551 [TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation. Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889 [TBL] [Abstract][Full Text] [Related]
8. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. Nakayama K; Furusu A; Xu Q; Konta T; Kitamura M J Immunol; 2001 Aug; 167(3):1145-50. PubMed ID: 11466328 [TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Kim KB; Myung J; Sin N; Crews CM Bioorg Med Chem Lett; 1999 Dec; 9(23):3335-40. PubMed ID: 10612595 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Meiners S; Laule M; Rother W; Guenther C; Prauka I; Muschick P; Baumann G; Kloetzel PM; Stangl K Circulation; 2002 Jan; 105(4):483-9. PubMed ID: 11815432 [TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors. Wesierska-Gadek J; Bohrn E; Herceg Z; Wang ZQ; Wurzer G J Cell Biochem; 2000 Jun; 78(4):681-96. PubMed ID: 10861865 [TBL] [Abstract][Full Text] [Related]
12. Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Rodgers KJ; Dean RT Int J Biochem Cell Biol; 2003 May; 35(5):716-27. PubMed ID: 12672463 [TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells. Wagenknecht B; Hermisson M; Eitel K; Weller M Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025 [TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway. Santiago-Josefat B; Fernandez-Salguero PM J Mol Biol; 2003 Oct; 333(2):249-60. PubMed ID: 14529614 [TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone. McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Zhang XM; Lin H; Chen C; Chen BD Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667 [TBL] [Abstract][Full Text] [Related]
17. Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide. El-Shami KM; Tirosh B; Popovic D; Carmon L; Tzehoval E; Vadai E; Feldman M; Eisenbach L Int J Cancer; 2000 Jan; 85(2):236-42. PubMed ID: 10629083 [TBL] [Abstract][Full Text] [Related]
18. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation. Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537 [TBL] [Abstract][Full Text] [Related]
19. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664 [TBL] [Abstract][Full Text] [Related]